ONCOLYTICS BIOTECH INC (ONCY) Stock News

NASDAQ:ONCY - Nasdaq - CA6823108759 - Common Stock - Currency: USD

1.27 -0.05 (-3.79%)

After market: 1.28 +0.01 (+0.79%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

ONCY Latest News, Press Relases and Analysis

All

Press Releases

3 days ago - By: Oncolytics Biotech® Inc.

Oncolytics Biotech® Presents Aggregated Translational Data Providing Evidence of Pelareorep's Effectiveness Across Multiple Tumor Types

9 days ago - By: Oncolytics Biotech® Inc.

Oncolytics Biotech® to Host Key Opinion Leader Discussion Focusing on Pancreatic and Gastrointestinal Cancers

11 days ago - By: FN Media Group LLC - Mentions: ONC.CA MBIO VSTM CRDF ...

Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies

11 days ago - By: Oncolytics Biotech® Inc.

Oncolytics Biotech® Highlights Transformative Pelareorep Survival Data in Multiple Tumors and Commitment to Registration-Enabling Studies

20 days ago - By: Oncolytics Biotech® Inc.

Oncolytics Biotech® Appoints Former Ambrx Executive as Chief Business Officer to Drive Business Development Strategy

a month ago - By: Oncolytics Biotech® Inc.

Oncolytics Biotech® Names New CEO to Accelerate Momentum in Immunotherapy Programs

2 months ago - By: Benzinga - Mentions: IXHL HOLO DGLY IMNN ...

Why E2open Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket

a month ago - By: FN Media Group LLC - Mentions: ONC.CA NVS PFE BNTX ...

Global Billion Dollar Oncology Industry Experiencing Substantial Growth Driven by Increasing Cancer Incidences